| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +590193.54% |
| VRNA | Verona Pharma Plc | $77.75B | +412890.43% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +346690.50% |
| ARGX | Argen X SE | $54.32B | +288462.41% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +207779.57% |
| ONC | BeiGene Ltd | $34.73B | +184397.64% |
| RVMD | Revolution Medicines Inc | $30.63B | +162590.87% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +125121.57% |
| BNTX | BioNTech SE | $23.52B | +124827.72% |
| INSM | Insmed Inc | $23.04B | +122276.32% |
| ROIV | Roivant Sciences Ltd | $21.31B | +113087.18% |
| INCY | Incyte Corp | $19.46B | +103286.38% |
| MRNA | Moderna Inc | $18.90B | +100302.09% |
| GMAB | Genmab | $17.06B | +90499.48% |
| ASND | Ascendis Pharma A/S | $15.18B | +80532.40% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +78012.05% |
| SMMT | Summit Therapeutics Inc | $13.47B | +71460.81% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +68970.34% |
| EXEL | Exelixis Inc | $12.69B | +67322.79% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +67307.85% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +64485.51% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +63957.47% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +58882.33% |
| ABVX | Abivax | $10.29B | +54541.10% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +53675.13% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +52751.09% |
| CYTK | Cytokinetics Inc | $9.51B | +50419.37% |
| KRYS | Krystal Biotech Inc | $9.03B | +47847.09% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +44773.37% |
| IBRX | ImmunityBio Inc | $8.26B | +43795.42% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +43121.24% |
| TECH | Bio-Techne Corp | $7.53B | +39882.30% |
| MTSR | Metsera Inc | $7.40B | +39233.11% |
| PCVX | Vaxcyte Inc | $7.36B | +39011.63% |
| CORT | Corcept Therapeutics Inc | $6.96B | +36874.33% |
| MRUS | Merus N.V | $6.83B | +36157.70% |
| IMVT | Immunovant Inc | $6.81B | +36093.76% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +35565.91% |
| ACLX | Arcellx Inc | $6.67B | +35309.08% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +34771.09% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +34397.24% |
| CELC | Celcuity Inc | $6.48B | +34306.04% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +33138.20% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +32587.47% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +31938.58% |
| TGTX | TG Therapeutics Inc | $6.00B | +31778.51% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +31493.32% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +31399.57% |
| COGT | Cogent Biosciences Inc | $5.89B | +31205.47% |
| PTCT | PTC Therapeutics Inc | $5.86B | +31009.14% |
| APGE | Apogee Therapeutics Inc | $5.82B | +30826.74% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +30266.71% |
| BLTE | Belite Bio Inc | $5.59B | +29592.82% |
| CGON | Cg Oncology Inc | $5.35B | +28323.57% |
| LEGN | Legend Biotech Corp | $5.26B | +27866.85% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +27780.73% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +27564.85% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +27307.10% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +25029.18% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +24997.06% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +23826.48% |
| TVTX | Travere Therapeutics Inc | $4.41B | +23342.72% |
| AKRO | Akero Therapeutics Inc | $4.38B | +23167.17% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +22991.94% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +22552.38% |
| ERAS | Erasca Inc | $3.88B | +20487.86% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +20481.16% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +20227.34% |
| VKTX | Viking Therapeutics Inc | $3.67B | +19390.62% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +19157.50% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +19049.21% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +17427.83% |
| BEAM | Beam Therapeutics Inc | $3.28B | +17304.28% |
| DNLI | Denali Therapeutics Inc | $3.21B | +16932.47% |
| RCUS | Arcus Biosciences Inc | $3.01B | +15879.60% |
| DYN | Dyne Therapeutics Inc | $3.00B | +15836.15% |
| ORKA | ARCA biopharma Inc | $2.91B | +15353.64% |
| TNGX | Tango Therapeutics Inc | $2.83B | +14947.66% |
| GPCR | Structure Therapeutics Inc | $2.81B | +14827.01% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +14463.13% |
| RLAY | Relay Therapeutics Inc | $2.73B | +14403.18% |
| ALMS | Alumis Inc | $2.67B | +14068.73% |
| IRON | Disc Medicine Inc | $2.66B | +14051.92% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +13948.19% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +13625.34% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +13564.61% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +13293.77% |
| IMNM | Immunome Inc | $2.50B | +13191.67% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +13044.28% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +12911.64% |
| ETNB | 89bio Inc | $2.34B | +12345.59% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +12113.43% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +11677.75% |
| KOD | Kodiak Sciences Inc | $2.18B | +11485.59% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +11091.79% |
| ZLAB | Zai Lab Ltd | $2.08B | +10922.43% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +10694.85% |
| MESO | Mesoblast Ltd | $2.02B | +10620.35% |
| TYRA | Tyra Biosciences Inc | $1.97B | +10378.40% |
| SION | Sionna Therapeutics Inc | $1.96B | +10298.86% |
| STOK | Stoke Therapeutics Inc | $1.96B | +10297.93% |
| NBTX | Nanobiotix | $1.94B | +10187.63% |
| AAPG | Ascentage Pharma Group International | $1.93B | +10166.01% |
| PHVS | Pharvaris NV | $1.92B | +10123.09% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +10069.87% |
| GLPG | Galapagos NV | $1.90B | +9983.50% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +9933.60% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +9830.05% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +9756.54% |
| ADMA | Adma Biologics Inc | $1.84B | +9672.55% |
| NVAX | Novavax Inc | $1.82B | +9586.06% |
| ZYME | Zymeworks BC Inc | $1.81B | +9526.40% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +9495.48% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +9355.28% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +9293.80% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +9253.96% |
| VCEL | Vericel Corp | $1.75B | +9185.89% |
| OCS | Oculis Holding AG | $1.74B | +9165.03% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +9123.38% |
| BHVN | Biohaven Ltd | $1.70B | +8926.16% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +8921.55% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +8835.19% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +8825.93% |
| ANAB | AnaptysBio Inc | $1.67B | +8796.38% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +8739.65% |
| ABCL | AbCellera Biologics Inc | $1.65B | +8683.12% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +8674.50% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +8624.49% |
| INVA | Innoviva Inc | $1.63B | +8576.39% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +8499.06% |
| NKTR | Nektar Therapeutics | $1.62B | +8493.35% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +8486.49% |
| QURE | uniQure N.V. | $1.59B | +8327.66% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +8288.80% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +8210.01% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +8164.51% |
| PGEN | Precigen Inc | $1.55B | +8144.20% |
| IMTX | Immatics N.V | $1.53B | +8046.44% |
| ARDX | Ardelyx Inc | $1.52B | +7994.49% |
| MBX | MBX Biosciences Inc | $1.52B | +7955.82% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +7892.10% |
| VIR | Vir Biotechnology Inc | $1.47B | +7693.85% |
| IMCR | Immunocore Holdings plc | $1.45B | +7600.88% |
| URGN | UroGen Pharma Ltd | $1.43B | +7488.73% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +7413.78% |
| GHRS | GH Research PLC | $1.39B | +7268.11% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +7191.46% |
| SEPN | Septerna Inc | $1.34B | +7007.73% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +6996.36% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +6870.07% |
| MAZE | Maze Therapeutics Inc | $1.30B | +6782.51% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +6643.69% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +6511.45% |
| TRML | Tourmaline Bio Inc | $1.24B | +6464.11% |
| WVE | Wave Life Sciences Ltd | $1.22B | +6377.50% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +5894.62% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +5889.06% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +5733.80% |
| MNKD | Mannkind Corp | $1.10B | +5725.20% |
| DBVT | DBV Technologies | $1.10B | +5718.48% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +5675.63% |
| SVRA | Savara Inc | $1.07B | +5571.27% |
| JBIO | Jade Biosciences Inc | $1.06B | +5535.65% |
| CVAC | CureVac N.V. | $1.05B | +5473.86% |
| ANNX | Annexon Inc | $1.05B | +5460.22% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +5205.14% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +5158.12% |
| CGEM | Cullinan Oncology Inc | $953.73M | +4966.14% |
| PHAR | Pharming Group N.V. | $940.58M | +4896.33% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +4807.11% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +4754.26% |
| KURA | Kura Oncology Inc | $908.93M | +4728.21% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +4710.61% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +4616.55% |
| JANX | Janux Therapeutics Inc | $878.90M | +4568.66% |
| XNCR | Xencor Inc | $868.03M | +4510.93% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +4432.22% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +4383.56% |
| GERN | Geron Corp | $843.41M | +4380.17% |
| EVMN | Evommune Inc | $841.03M | +4367.50% |
| VOR | Vor Biopharma Inc | $840.96M | +4367.14% |
| TBPH | Theravance Biopharma Inc | $837.63M | +4349.47% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +4333.88% |
| SANA | Sana Biotechnology Inc | $825.64M | +4285.76% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +4178.79% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +4134.48% |
| OMER | Omeros Corporation | $797.02M | +4133.76% |
| ABSI | Absci Corp | $789.28M | +4092.63% |
| CMRX | Chimerix Inc | $766.03M | +3969.11% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +3945.07% |
| ANRO | Alto Neuroscience Inc | $714.55M | +3695.65% |
| ATXS | Astria Therapeutics Inc | $709.95M | +3671.22% |
| DSGN | Design Therapeutics Inc | $693.10M | +3581.71% |
| SLDB | Solid Biosciences Inc | $690.73M | +3569.13% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +3528.90% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +3487.75% |
| CRMD | CorMedix Inc | $663.22M | +3423.01% |
| IVA | Inventiva | $655.21M | +3380.47% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +3338.47% |
| CABA | Cabaletta Bio Inc | $640.38M | +3301.69% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +3297.58% |
| PRME | Prime Medicine Inc | $596.03M | +3066.09% |
| CADL | Candel Therapeutics Inc | $589.73M | +3032.59% |
| CBIO | Crescent Biopharma Inc | $573.22M | +2944.92% |
| TECX | AvroBio Inc | $573.01M | +2943.80% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +2934.78% |
| ARVN | Arvinas Inc | $570.83M | +2932.19% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +2826.02% |
| VALN | Valneva SE | $545.52M | +2797.79% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +2783.25% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +2772.26% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +2759.42% |
| MDXG | Mimedx Group Inc | $537.64M | +2755.93% |
| PRTA | Prothena Corporation plc | $532.36M | +2727.89% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +2662.08% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +2565.73% |
| XOMA | XOMA Corp | $497.12M | +2540.66% |
| STRO | Sutro Biopharma Inc | $491.87M | +2512.78% |
| OCGN | Ocugen Inc | $466.88M | +2380.04% |
| SVA | Sinovac Biotech Ltd | $464.94M | +2369.73% |
| IMMX | Immix Biopharma Inc | $462.80M | +2358.35% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +2357.33% |
| STTK | Shattuck Labs Inc | $458.03M | +2333.01% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +2298.89% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +2297.87% |
| UPB | Upstream Bio Inc | $449.51M | +2287.77% |
| AUTL | Autolus Therapeutics plc | $447.12M | +2275.08% |
| ADCT | Adc Therapeutics SA | $438.08M | +2227.08% |
| ASMB | Assembly Biosciences Inc | $435.45M | +2213.09% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +2197.02% |
| AURA | Aura Biosciences Inc | $430.49M | +2186.74% |
| OVID | Ovid Therapeutics Inc | $424.86M | +2156.82% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +2128.87% |
| IPSC | Century Therapeutics Inc | $415.14M | +2105.18% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +2072.25% |
| CMPX | Compass Therapeutics Inc | $408.80M | +2071.52% |
| CYBN | Cybin Inc | $408.43M | +2069.57% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +2044.77% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +2041.86% |
| BNTC | Benitec Biopharma Inc | $398.51M | +2016.87% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +1973.17% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +1972.66% |
| CCCC | C4 Therapeutics Inc | $389.10M | +1966.86% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +1963.55% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +1936.15% |
| RVNC | Revance Therapeutics Inc | $380.38M | +1920.54% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +1919.12% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +1903.14% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +1902.52% |
| OABI | OmniAb Inc | $374.99M | +1891.93% |
| REPL | Replimune Group Inc | $374.27M | +1888.09% |
| ALT | Altimmune Inc | $373.67M | +1884.94% |
| VSTM | Verastem Inc | $373.33M | +1883.13% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +1880.95% |
| PBYI | Puma Biotechnology Inc | $371.93M | +1875.66% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +1842.41% |
| CLLS | Cellectis | $364.91M | +1838.41% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +1834.21% |
| EDIT | Editas Medicine Inc | $349.39M | +1755.92% |
| PALI | Palisade Bio Inc | $346.56M | +1740.93% |
| RGNX | Regenxbio Inc | $345.32M | +1734.31% |
| IMRX | Immuneering Corp Class A | $344.95M | +1732.38% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +1729.30% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +1723.50% |
| FBRX | Forte Biosciences Inc | $340.15M | +1706.87% |
| IMAB | I-Mab | $339.64M | +1704.13% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +1677.18% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +1645.98% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +1634.78% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +1633.18% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +1627.98% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +1618.79% |
| SLN | Silence Therapeutics Plc | $321.20M | +1606.17% |
| RZLT | Rezolute Inc | $319.69M | +1598.18% |
| IVVD | Invivyd Inc | $319.57M | +1597.53% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +1592.18% |
| ANL | Adlai Nortye Ltd | $317.46M | +1586.31% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +1520.46% |
| SCPH | scPharmaceuticals Inc | $304.59M | +1517.97% |
| NAGE | Niagen Bioscience Inc | $304.32M | +1516.53% |
| SRZN | Surrozen Inc | $304.03M | +1514.97% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +1508.79% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +1471.39% |
| IRD | Ocuphire Pharma Inc | $295.61M | +1470.25% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +1436.85% |
| ACIU | AC Immune SA | $289.11M | +1435.75% |
| TENX | Tenax Therapeutics Inc | $288.39M | +1431.93% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +1419.47% |
| YDES | YD Bio Ltd | $278.91M | +1381.55% |
| MGNX | Macrogenics Inc | $278.39M | +1378.81% |
| FATE | Fate Therapeutics Inc | $275.57M | +1363.79% |
| CNTX | Context Therapeutics Inc | $273.80M | +1354.41% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +1348.47% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +1330.16% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +1300.76% |
| TARA | Protara Therapeutics Inc | $262.06M | +1292.07% |
| CGEN | Compugen Ltd | $260.97M | +1286.24% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +1267.19% |
| CHRS | Coherus Biosciences Inc | $256.00M | +1259.87% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +1258.66% |
| HUMA | Humacyte Inc | $255.32M | +1256.26% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +1231.67% |
| ALEC | Alector Inc | $245.37M | +1203.37% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +1187.45% |
| THRD | Third Harmonic Bio Inc | $241.86M | +1184.77% |
| CDXS | Codexis Inc | $239.96M | +1174.66% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +1159.04% |
| ADAG | Adagene Inc | $236.93M | +1158.55% |
| NKTX | Nkarta Inc | $236.88M | +1158.31% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +1137.75% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +1130.20% |
| NERV | Minerva Neurosciences Inc | $230.61M | +1124.98% |
| SLRN | Acelyrin Inc | $228.54M | +1114.02% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +1098.37% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +1092.30% |
| CRBU | Caribou Biosciences Inc | $223.96M | +1089.65% |
| KROS | Keros Therapeutics Inc | $223.18M | +1085.51% |
| RNA | Atrium Therapeutics Inc | $222.37M | +1081.24% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +1061.23% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +1056.52% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +992.09% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +975.38% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +971.98% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +966.38% |
| KRRO | Korro Bio Inc | $198.45M | +954.18% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +950.78% |
| DTIL | Precision Biosciences Inc | $195.87M | +940.43% |
| IMUX | Immunic Inc | $190.70M | +912.99% |
| QTTB | Q32 Bio Inc | $187.99M | +898.59% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +886.07% |
| MDWD | MediWound Ltd | $184.49M | +879.98% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +874.52% |
| THAR | Tharimmune Inc | $183.00M | +872.09% |
| IFRX | InflaRx N.V. | $182.18M | +867.72% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +860.46% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +847.82% |
| GALT | Galectin Therapeutics Inc | $177.81M | +844.54% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +821.85% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +816.84% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +816.82% |
| HRTX | Heron Therapeutics Inc | $172.54M | +816.52% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +813.04% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +808.32% |
| SPRO | Spero Therapeutics Inc | $169.62M | +801.02% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +799.21% |
| THTX | Theratechnologies Inc | $167.34M | +788.88% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +785.04% |
| EQ | Equillium Inc | $166.29M | +783.30% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +776.01% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +773.10% |
| MENS | Jyong Biotech Ltd | $164.22M | +772.33% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +765.24% |
| IPHA | Innate Pharma | $159.97M | +749.76% |
| TTRX | Turn Therapeutics Inc | $157.58M | +737.05% |
| MOLN | Molecular Partners AG | $154.89M | +722.74% |
| VXRT | Vaxart Inc | $153.61M | +715.98% |
| HURA | TuHURA Biosciences Inc | $151.32M | +703.79% |
| NBP | NovaBridge Biosciences. | $150.91M | +701.64% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +699.49% |
| AKTX | Akari Therapeutics Plc | $148.12M | +686.83% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +672.13% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +663.95% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +660.98% |
| PROK | ProKidney Corp - Class A | $137.85M | +632.25% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +631.06% |
| GNLX | Genelux Corp | $137.21M | +628.86% |
| GUTS | Fractyl Health Inc | $136.31M | +624.08% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +603.13% |
| AGEN | Agenus Inc | $131.36M | +597.77% |
| ACOG | Alpha Cognition Inc | $124.77M | +562.75% |
| CRDF | Cardiff Oncology Inc | $123.75M | +557.35% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +539.98% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +537.59% |
| SEER | Seer Inc - Class A | $115.64M | +514.29% |
| ENGN | enGene Holdings Inc | $115.22M | +512.05% |
| RPTX | Repare Therapeutics Inc | $113.91M | +505.10% |
| COYA | Coya Therapeutics Inc | $111.89M | +494.36% |
| PYXS | Pyxis Oncology Inc | $108.70M | +477.40% |
| VANI | Vivani Medical Inc | $108.35M | +475.55% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +464.82% |
| HLVX | HilleVax Inc | $104.74M | +456.37% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +455.18% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +452.99% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +447.92% |
| PEPG | PepGen Inc | $103.13M | +447.81% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +443.96% |
| BMEA | Biomea Fusion Inc | $98.33M | +422.31% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +419.53% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +419.19% |
| ICCC | Immucell Corp | $96.17M | +410.84% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +398.99% |
| ATHA | Athira Pharma Inc | $92.15M | +389.50% |
| FBIO | Fortress Biotech Inc | $91.60M | +386.55% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +382.61% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +376.57% |
| ANIX | Anixa Biosciences Inc | $88.68M | +371.05% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +367.97% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +363.29% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +362.39% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +362.09% |
| PYPD | Polypid Ltd | $86.83M | +361.25% |
| NRXS | Neuraxis Inc | $85.30M | +353.12% |
| LPTX | Leap Therapeutics Inc | $84.76M | +350.23% |
| CSBR | Champions Oncology Inc | $82.35M | +337.43% |
| ACET | Adicet Bio Inc | $81.58M | +333.35% |
| HYFT | MindWalk Holdings Corp | $79.54M | +322.52% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +322.19% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +313.92% |
| FBIOP | Fortress Biotech Inc | $77.72M | +312.85% |
| RLYB | Rallybio Corp | $76.87M | +308.31% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +307.82% |
| GANX | Gain Therapeutics Inc | $75.20M | +299.48% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +296.72% |
| XBIT | XBiotech Inc | $74.39M | +295.16% |
| OSTX | OS Therapies Inc | $74.24M | +294.34% |
| MCRB | Seres Therapeutics Inc | $73.19M | +288.78% |
| SAVA | Cassava Sciences Inc. | $72.46M | +284.91% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +282.07% |
| EDSA | Edesa Biotech Inc | $70.82M | +276.19% |
| BYSI | BeyondSpring Inc | $70.31M | +273.51% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +265.00% |
| SPRB | Spruce Biosciences Inc | $67.96M | +260.97% |
| CUE | Cue Biopharma Inc | $66.52M | +253.37% |
| IMA | Ikena Oncology Inc | $66.48M | +253.15% |
| MNOV | Medicinova Inc | $65.46M | +247.74% |
| IBIO | iBio Inc | $64.94M | +244.97% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +241.65% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +239.95% |
| IMMP | Immutep Ltd | $63.92M | +239.55% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +237.59% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +235.94% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +235.82% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +229.10% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +225.37% |
| GLTO | Galecto Inc | $60.81M | +223.02% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +214.47% |
| ANVS | Annovis Bio Inc | $57.22M | +203.94% |
| DWTX | Virios Therapeutics Inc | $57.12M | +203.40% |
| ENTX | Entera Bio Ltd | $55.48M | +194.71% |
| TIL | Instil Bio Inc | $55.21M | +193.25% |
| KZR | Kezar Life Sciences Inc | $53.76M | +185.57% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +180.64% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +180.00% |
| NBY | Stablecoin Development Corp | $52.10M | +176.74% |
| RNTX | Rein Therapeutics Inc | $51.79M | +175.13% |
| GOSS | Gossamer Bio Inc | $51.14M | +171.65% |
| MGX | Metagenomi Inc | $50.82M | +169.97% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +165.77% |
| INKT | MiNK Therapeutics Inc | $48.84M | +159.45% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +157.31% |
| XLO | Xilio Therapeutics Inc | $48.23M | +156.18% |
| CING | Cingulate Inc | $47.16M | +150.50% |
| ATYR | Atyr Pharma Inc | $46.89M | +149.07% |
| LVTX | LAVA Therapeutics NV | $45.77M | +143.13% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +142.90% |
| PSTV | Plus Therapeutics Inc | $45.56M | +142.03% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +134.20% |
| KALA | Kala Bio Inc | $43.31M | +130.08% |
| RNXT | RenovoRx Inc | $41.96M | +122.88% |
| NTRB | Nutriband Inc | $41.39M | +119.87% |
| HYPD | Eyenovia Inc | $41.14M | +118.55% |
| FGEN | FibroGen Inc | $39.31M | +108.79% |
| NNVC | NanoViricides Inc | $37.88M | +101.23% |
| VERU | Veru Inc | $37.40M | +98.65% |
| LTRN | Lantern Pharma Inc | $37.25M | +97.89% |
| INMB | INmune Bio Inc | $37.22M | +97.71% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +95.00% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +91.79% |
| GRCE | Acasti Pharma Inc | $36.05M | +91.52% |
| GBIO | Generation Bio Company | $35.97M | +91.06% |
| ABVC | ABVC BioPharma Inc | $35.82M | +90.26% |
| MURA | Mural Oncology plc | $35.34M | +87.74% |
| LITS | Lite Strategy Inc | $35.16M | +86.75% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +84.08% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +82.20% |
| DARE | Dare Bioscience Inc | $33.92M | +80.20% |
| EVAX | Evaxion Biotech A/S | $33.82M | +79.65% |
| BOLD | Boundless Bio Inc | $32.94M | +74.97% |
| SNTI | Senti Biosciences Inc | $31.46M | +67.09% |
| TVRD | Cara Therapeutics Inc | $30.96M | +64.45% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +59.65% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +59.22% |
| APLM | Apollomics Inc - Class A | $29.93M | +58.99% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +54.84% |
| SKYE | Skye Bioscience Inc | $29.10M | +54.59% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +54.25% |
| GRDX | Entero Therapeutics Inc | $28.95M | +53.80% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +51.85% |
| CRVO | CervoMed Inc | $28.15M | +49.51% |
| IGC | IGC Pharma Inc | $28.00M | +48.73% |
| DYAI | Dyadic International Inc DE | $27.40M | +45.54% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +45.37% |
| SER | AgeX Therapeutics Inc | $26.82M | +42.46% |
| PLRZ | Polyrizon Ltd | $26.52M | +40.87% |
| CELU | Celularity Inc - Class A | $26.39M | +40.18% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +40.02% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +39.81% |
| PTN | Palatin Technologies Inc | $26.08M | +38.51% |
| TPST | Tempest Therapeutics Inc | $25.68M | +36.39% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +34.20% |
| PLUR | Pluri Inc | $24.62M | +30.76% |
| MRKR | Marker Therapeutics Inc | $24.21M | +28.63% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +26.49% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +20.46% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +18.54% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +17.54% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +16.63% |
| NXTC | Nextcure Inc | $21.90M | +16.32% |
| OPT | Opthea Ltd | $21.53M | +14.36% |
| CRIS | Curis Inc | $21.11M | +12.13% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +8.24% |
| LGVN | Longeveron Inc - Class A | $19.70M | +4.66% |
| GNTA | Genenta Science SpA | $19.23M | +2.13% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +0.39% |
| XCUR | Exicure Inc | $17.78M | -5.54% |
| INAB | IN8bio Inc | $17.72M | -5.85% |
| PASG | Passage Bio Inc | $17.71M | -5.94% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | -8.20% |
| MTVA | MetaVia Inc | $17.25M | -8.37% |
| LPCN | Lipocine Inc | $17.04M | -9.47% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | -12.08% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | -14.39% |
| HIND | ReShape Lifesciences Inc | $15.72M | -16.49% |
| COCP | Cocrystal Pharma Inc | $15.44M | -17.98% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | -17.98% |
| LEXX | Lexaria Bioscience Corp | $15.24M | -19.05% |
| CLRB | Cellectar Biosciences Inc | $14.97M | -20.49% |
| QNCX | Quince Therapeutics Inc | $14.89M | -20.88% |
| APLT | Applied Therapeutics Inc | $14.86M | -21.05% |
| HOOK | Hookipa Pharma Inc | $14.68M | -22.03% |
| BLRX | Bioline Rx Ltd | $14.66M | -22.11% |
| MBRX | Moleculin Biotech Inc | $14.57M | -22.61% |
| IOBT | IO Biotech Inc | $14.50M | -22.99% |
| ICU | SeaStar Medical Holding Corp | $14.34M | -23.84% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | -24.85% |
| GTBP | GT Biopharma Inc | $13.91M | -26.12% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | -27.41% |
| TOVX | Theriva Biologics Inc | $13.51M | -28.26% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | -29.03% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | -30.84% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | -31.00% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | -32.12% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | -34.48% |
| CALC | CalciMedica Inc | $11.72M | -37.72% |
| LNAI | Lunai Bioworks Inc | $11.72M | -37.77% |
| TRAW | Traws Pharma Inc | $11.70M | -37.86% |
| INTS | Intensity Therapeutics Inc | $11.33M | -39.81% |
| BIVI | BioVie Inc - Class A | $11.16M | -40.71% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | -40.82% |
| BRTX | BioRestorative Therapies Inc | $11.03M | -41.41% |
| APRE | Aprea Therapeutics Inc | $10.96M | -41.78% |
| KAPA | Kairos Pharma Ltd | $10.68M | -43.25% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -44.61% |
| CVM | Cel-Sci Corp | $10.15M | -46.11% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | -46.21% |
| MLEC | Moolec Science SA | $10.06M | -46.58% |
| BCDA | BioCardia Inc | $9.85M | -47.68% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | -47.91% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | -48.32% |
| SNGX | Soligenix Inc | $9.11M | -51.63% |
| IMNN | Imunon Inc | $9.02M | -52.07% |
| EPIX | Essa Pharma Inc | $8.93M | -52.56% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -52.63% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | -53.27% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | -53.77% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | -54.64% |
| IMRN | Immuron Ltd | $8.36M | -55.60% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | -56.66% |
| LIMN | Liminatus Pharma Inc | $8.08M | -57.09% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -57.18% |
| NCNA | NuCana plc | $7.95M | -57.78% |
| ADXN | Addex Therapeutics Ltd | $7.90M | -58.04% |
| SYBX | Synlogic Inc | $7.72M | -58.98% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | -59.29% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -61.03% |
| XBIO | Xenetic Biosciences Inc | $7.06M | -62.47% |
| GNPX | Genprex Inc | $7.02M | -62.70% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | -62.91% |
| EVGN | Evogene Ltd | $6.91M | -63.27% |
| SILO | SILO Pharma Inc | $6.78M | -63.97% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | -64.17% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | -64.50% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -66.00% |
| GOVX | Geovax Labs Inc | $6.29M | -66.61% |
| APM | Aptorum Group Ltd - Class A | $6.26M | -66.77% |
| BCAB | BioAtla Inc | $6.19M | -67.12% |
| PPBT | Purple Biotech Ltd | $6.05M | -67.87% |
| APVO | Aptevo Therapeutics Inc | $5.83M | -69.05% |
| BGMS | Bio Green Med Solution Inc | $5.30M | -71.85% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | -72.11% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -72.22% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | -72.49% |
| HCWB | HCW Biologics Inc | $5.10M | -72.92% |
| PULM | Pulmatrix Inc | $4.97M | -73.61% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -73.92% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | -73.94% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | -75.14% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | -75.21% |
| ALZN | Alzamend Neuro Inc | $4.38M | -76.76% |
| MBIO | Mustang Bio Inc | $4.29M | -77.21% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -77.34% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -77.35% |
| REVB | Revelation Biosciences Inc | $4.26M | -77.37% |
| FBLG | FibroBiologics Inc | $4.23M | -77.55% |
| ENVB | Enveric Biosciences Inc | $4.15M | -77.94% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -78.02% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -78.32% |
| PHGE | BiomX Inc | $3.91M | -79.25% |
| PBM | Psyence Biomedical Ltd | $3.76M | -80.01% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -80.25% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -80.84% |
| VIVS | VivoSim Labs Inc | $3.36M | -82.13% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -82.25% |
| AZTR | Azitra Inc | $3.32M | -82.36% |
| GRI | GRI Bio Inc | $3.30M | -82.49% |
| SPRC | SciSparc Ltd | $3.05M | -83.82% |
| AFMD | Affimed N.V. | $2.98M | -84.20% |
| CMND | Clearmind Medicine Inc | $2.88M | -84.69% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -84.72% |
| ARTL | Artelo Biosciences Inc | $2.75M | -85.41% |
| OGEN | Oragenics Inc | $2.58M | -86.31% |
| PPCB | Propanc Biopharma Inc | $2.50M | -86.71% |
| NTBL | Notable Labs Inc Ord | $2.39M | -87.28% |
| BBLG | Bone Biologics Corp | $2.23M | -88.17% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -88.60% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -88.91% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -89.41% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -90.73% |
| ONCO | Onconetix Inc | $1.61M | -91.44% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -91.72% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -91.74% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -91.75% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -91.93% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -92.42% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -92.65% |
| JAGX | Jaguar Health Inc | $1.34M | -92.86% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -93.09% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -94.65% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -95.11% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -97.07% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -97.63% |
| ELAB | PMGC Holdings Inc | $221376.00 | -98.82% |
| ADTX | Aditxt Inc | $132564.52 | -99.30% |
| CDT | CDT Equity Inc | $110551.31 | -99.41% |